Interest to consider re-challenging by cetuximab and platinum containing regimen in recurrent Head and Neck Cancer.
Borel C, Regnier-Gavier O, Carinato H, Guihard S, Antoni D, Demarchi M, Sirlin F, Exinger D, Petit-Jean E, Thiery A, Bronner G, Schultz P, Flesch H, Frasie V, Prébay D, Petit T, Jung AC, Burgy M, Coliat P.
Borel C, et al. Among authors: frasie v.
Oncotarget. 2018 Dec 25;9(101):37581-37588. doi: 10.18632/oncotarget.26506. eCollection 2018 Dec 25.
Oncotarget. 2018.
PMID: 30680071
Free PMC article.